Clinical Accelerator




Clinical Accelerator conducts all phases of clinical trials for pharma, biotech and medtech companies. We have a very simple mission: to accelerate clinical development projects and to reduce their cost appreciably for our clients.
We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines.
We routinely rescue stalled clinical trials.
The cost of our studies is among the most attractive globally. We commit to our budgets and fix them for our clients.

Contact Clinical Accelerator via their website


News archive

17/09/2018   Clinical Accelerator announces collaboration with Oncolix...more

03/08/2018   VisCardia Inc. announces commencement of Clinical Accelerator pilot study in Ukraine...more
16/07/2018   Clinical Accelerator reports high quality trial data for Central and Eastern Europe...more
12/06/2018   Clinical Accelerator reports ARREST Phase IIb study results...more
03/05/2018   Noxopharm announces start of DARRT-1 clinical study conducted by Clinical Accelerator...more
17/04/2018   Replicor presents long-term data from study conducted by Clinical Accelerator...more

11/12/2017   Clinical Accelerator announces collaboration with VisCardia...more
28/02/2017   Clinical Accelerator forms ClinAccel.Net...more

05/05/2016   Clinical Accelerator to Exhibit at Bio International 2016...more
04/05/2016   Clinical Accelerator Annouce Collaboration With Galmed...more

10/11/2014   Clinical Accelerator joins the BioPartner Programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code